A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States.
about
Pathogen inactivation technologies for cellular blood components: an updatePathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?Cost implications of implementation of pathogen-inactivated plateletsSafety of platelet transfusion: past, present and future.Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione.Investigation of bacterial inactivation in apheresis platelets with 24 or 30 hours between inoculation and inactivation.Bacterial testing of platelets - has it prevented transfusion-transmitted bacterial infections in Australia?Bacterial contamination of platelets for transfusion: strategies for prevention
P2860
Q28655769-2700CFEC-0F09-418C-B7DF-443A7979DC9CQ33841435-46016940-2966-4B4A-A833-2BD9E8F3BD66Q36404706-C1ACD3B2-5262-490C-AD3C-53D95671841FQ38197714-4641798D-4836-4295-A9E6-1351D10106CAQ40611312-27C71508-0879-40EF-8B6C-FD158DBFE0C6Q41935541-ABEDA6D6-8149-444B-AAC0-4A0B103D9663Q46474701-3A3FE718-C85A-486D-8B7F-615049416E00Q48283110-D156A6CF-642A-4F4D-9643-5089A14E2B34Q58110468-DCC34801-C0B9-49EF-9E96-D837FB92468D
P2860
A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A patient-oriented risk-benefi ...... latelets in the United States.
@en
type
label
A patient-oriented risk-benefi ...... latelets in the United States.
@en
prefLabel
A patient-oriented risk-benefi ...... latelets in the United States.
@en
P2860
P1433
P1476
A patient-oriented risk-benefi ...... latelets in the United States.
@en
P2093
Steven Kleinman
William Reed
P2860
P304
P356
10.1111/J.1537-2995.2012.03928.X
P577
2012-10-15T00:00:00Z